台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    90.6
  • 漲跌
    ▲0.3
  • 漲幅
    +0.33%
  • 成交量
    492
  • 產業
    上櫃 生技醫療類股
  • 303人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-富邦-木柵 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-木柵 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/29191.9000.0091.5017470.13%
2024/05/24493.0000.0092.8048080.49%
2024/05/2200.00894.8994.10-8847-0.94%
2024/05/16295.4000.0095.1028690.23%
2024/05/14195.0000.0094.3011,0430.10%
2024/05/09193.5000.0093.3011,0720.09%
2024/05/0700.00193.1092.80-11,116-0.09%
2024/04/24390.87190.8090.7021,4550.14%
2024/04/0300.00299.4599.00-21,777-0.11%
2024/04/012100.502100.0099.6001,8050.00%
2024/03/29298.7000.0099.2021,8130.11%
2024/03/2800.004100.0099.40-41,839-0.22%
2024/03/2700.008.698.4699.70-8.61,828-0.47%
2024/03/2631.596.881096.8096.8021.51,8181.18%
2024/03/25499.9300.00101.0041,8160.22%
2024/03/220.196.0000.0096.500.11,8010.01%
2024/03/210.495.8500.0096.000.41,8270.02%
2024/03/196.197.03196.6096.805.11,8640.27%
2024/03/180.193.4200.0093.300.11,8550.01%
2024/03/122.496.0500.0095.602.41,8890.13%
2024/03/11395.60395.4095.1001,9040.00%
2024/03/0800.009.195.7095.10-9.11,924-0.47%
2024/03/07295.0000.0099.3021,9300.10%
2024/03/06498.85298.8598.1021,9370.10%
2024/03/0400.006.5100.78100.50-6.51,924-0.34%
2024/03/011.2103.8700.00101.501.21,9390.06%
2024/02/271105.0000.00103.0011,9950.05%
2024/02/262103.502104.00104.5001,9900.00%
2024/02/231102.007101.43101.00-61,981-0.30%
2024/02/2200.007101.14101.00-72,018-0.35%
2024/02/213103.0000.00101.5032,0430.15%
2024/02/2000.001101.00101.50-12,058-0.05%
2024/02/162102.5000.00102.0022,0960.10%
2024/02/1511110.736.4111.50110.504.62,0600.22%
2024/02/011107.0000.00107.0012,2810.04%
2024/01/312107.001106.00106.0012,3960.04%
2024/01/291108.5000.00106.0012,7600.04%
2024/01/267108.647111.93108.5002,8380.00%
2024/01/2500.008102.31105.00-82,782-0.29%
2024/01/24999.541100.00100.5082,8960.28%
2024/01/23199.8000.0099.4013,0720.03%
2024/01/22699.201199.89100.50-53,404-0.15%
2024/01/1900.000.198.1098.50-0.13,6250.00%
2024/01/17199.2000.0098.3014,0790.02%
2024/01/1500.002105.25104.50-24,586-0.04%
2024/01/121104.0000.00103.0014,6030.02%
2024/01/111102.0000.00101.5014,6090.02%
2024/01/105102.5000.00102.0054,6150.11%
2024/01/051105.001106.50109.0004,6070.00%
2024/01/0400.007104.79103.00-74,593-0.15%
2024/01/034109.501110.00106.0034,6250.06%
2024/01/0200.007108.79110.00-74,583-0.15%
2023/12/2800.001104.50104.00-14,524-0.02%
2023/12/275106.101106.00105.0044,5160.09%
2023/12/252104.5000.00105.0024,4770.04%
2023/12/2200.003.6101.42101.50-3.64,445-0.08%
2023/12/2000.000104.00102.5004,4360.00%
2023/12/192.4103.0400.00103.502.44,4220.05%
2023/12/1500.001103.00104.00-14,397-0.02%
2023/12/141101.001102.00101.0004,3770.00%
2023/12/1100.00199.4097.80-14,378-0.02%
2023/12/071101.0000.00100.0014,3420.02%
2023/12/053102.501101.00101.5024,3210.05%
2023/12/0118103.729104.00103.0094,2770.21%
2023/11/301101.0000.00100.5014,2290.02%
2023/11/291100.502100.50101.00-14,229-0.02%
2023/11/271.4103.891106.50103.000.44,2360.01%
2023/11/242104.001103.50104.0014,1770.02%
2023/11/232103.502104.50104.0004,1540.00%
2023/11/222101.7500.00101.5024,1250.05%
2023/11/210102.501101.50101.00-14,102-0.02%
2023/11/2021.5104.6720103.50102.001.54,0630.04%
2023/11/172103.253102.50102.50-14,038-0.02%
2023/11/153104.6700.00103.5033,9850.08%
2023/11/107115.071113.00106.5063,9260.15%
2023/11/090.1112.0000.00111.000.13,7260.00%
2023/11/081113.5015110.70112.50-143,665-0.38%
2023/11/0732119.2818118.22114.00143,5380.40%
2023/11/061113.501115.00115.5003,2160.00%
2023/11/0300.004116.00112.00-43,144-0.13%
2023/11/0200.001113.50114.00-13,014-0.03%
2023/11/011114.5000.00114.5012,8870.03%
2023/10/3100.0058115.96113.50-582,729-2.12%
2023/10/3059.1116.2612117.50116.0047.12,5591.84%
2023/10/278113.068114.25118.0002,2290.00%
2023/10/261111.5000.00107.5012,0010.05%
2023/10/252111.502112.50111.5001,8020.00%
2023/10/2417106.716102.92110.00111,5450.71%
2023/10/23299.00299.60100.0001,1170.00%
2023/10/18190.60087.5087.3011,0050.10%
2023/10/17292.0000.0090.3029950.20%
2023/10/13295.8500.0092.9021,0100.20%
2023/10/12295.30395.2795.00-1985-0.10%
2023/10/06291.20291.0590.0009410.00%
2023/09/2000.00188.5089.80-11,061-0.09%
2023/09/1900.00288.6088.60-21,067-0.19%
2023/09/18389.07189.4087.6021,0600.19%
2023/09/12183.4000.0083.5011,0500.10%
2023/09/06186.8000.0087.0011,0630.09%
2023/09/01289.45390.5089.10-11,071-0.09%
2023/08/3100.00885.8586.90-81,028-0.78%
2023/08/30285.60285.9085.8001,0290.00%
2023/08/21286.30285.9086.1001,0720.00%
2023/08/1800.00186.4085.40-11,098-0.09%
2023/08/1700.00286.3084.90-21,109-0.18%
2023/08/1600.00385.6387.00-31,094-0.27%
2023/08/1500.00280.1081.00-21,053-0.19%
2023/08/14281.3000.0081.3021,0560.19%
2023/08/02183.0000.0081.9011,1330.09%
2023/07/31185.5000.0084.5011,1420.09%
2023/07/27187.2000.0086.2011,1680.09%
2023/07/2600.00186.6085.00-11,180-0.08%
2023/07/25187.9000.0087.5011,1720.09%
2023/07/24186.0000.0086.0011,1590.09%
2023/07/2100.00287.9087.10-21,167-0.17%
2023/07/2000.00189.0088.90-11,183-0.08%
2023/07/19190.0000.0089.8011,1920.08%
2023/07/14188.50289.1588.20-11,280-0.08%
2023/07/12186.5000.0086.0011,2730.08%
2023/07/11188.6000.0087.8011,2730.08%
2023/07/0700.00393.8393.80-31,247-0.24%
2023/07/06196.5000.0094.8011,2480.08%
2023/07/0500.00196.4096.20-11,287-0.08%
2023/07/03196.00295.7095.30-11,337-0.07%
2023/06/3000.00197.7097.50-11,342-0.07%
2023/06/29196.90196.4096.8001,3520.00%
2023/06/27195.40195.3094.6001,4280.00%
2023/06/20293.9500.0093.2021,5490.13%
2023/06/12194.6000.0094.2011,6210.06%
2023/06/0900.001296.1095.90-121,658-0.72%
2023/06/08196.7000.0095.7011,6910.06%
2023/06/0700.00196.9096.50-11,725-0.06%
2023/05/23297.60199.1099.0011,9430.05%
2023/05/17195.8000.0094.6012,0470.05%
2023/05/1500.00192.2092.60-12,088-0.05%
2023/04/2800.00198.3097.90-12,872-0.03%
2023/04/27195.8000.0096.0012,9380.03%
2023/04/2600.00195.6096.00-13,085-0.03%
2023/04/2500.00196.8097.00-13,132-0.03%
2023/04/2000.002107.25103.50-23,315-0.06%
2023/04/1800.000.5105.00105.00-0.53,402-0.01%
2023/04/1100.002107.00106.50-24,052-0.05%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章